{"id":60010,"date":"2026-02-27T02:10:46","date_gmt":"2026-02-27T02:10:46","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/apheresis-market-mordor\/"},"modified":"2026-09-18T13:52:40","modified_gmt":"2026-09-18T04:52:40","slug":"apheresis-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/apheresis-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc131\ubd84\ucc44\uc9d1\uc220 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/apheresis-market_1667447689293_241555.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/apheresis-market-size-image-1771921574403.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \ud608\uc561\ud559\uc801 &amp; \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \ud608\uc7a5 \uc720\ub798 \uce58\ub8cc\uc81c &amp; \ud608\uc561 \uc131\ubd84\uc5d0 \ub300\ud55c \uc218\uc694 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc790\ub3d9\ud654 &amp; \ub9c9 \uc5ec\uacfc \uae30\uc220 \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.4 \ubc31\ud608\uad6c\ubd84\ubc18\uc220\uc774 \ud544\uc694\ud55c \uc138\ud3ec &amp; \uc720\uc804\uc790 \uce58\ub8cc\uc758 \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.5 \ud734\ub300\uc6a9 \ud604\uc7a5 \uc9c4\ub8cc \uc131\ubd84\ucc44\uc9d1\uc220 \uc2dc\uc2a4\ud15c\uc758 \ub4f1\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc800\ud3d0\uae30\ubb3c \uc77c\ud68c\uc6a9 \ud0a4\ud2b8\uc5d0 \ub300\ud55c ESG \uae30\ubc18 \ud22c\uc790<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \uc790\ubcf8 &amp; \uc18c\ubaa8\ud488 \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc219\ub828\ub41c \uc804\ubb38\uac00 \ubd80\uc871<\/li>\n<li class=\"toc-level-3\">4.3.3 \ud544\uc218 \uc77c\ud68c\uc6a9\ud488\uc5d0 \ub300\ud55c \uacf5\uae09\ub9dd \uc704\ud5d8<\/li>\n<li class=\"toc-level-3\">4.3.4 \ubcd1\uc6d0\uccb4 \uac10\uc18c \uc804\ud608 \uae30\uc220\uacfc\uc758 \uacbd\uc7c1<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1\uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc81c\ud488\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc7a5\uce58<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc77c\ud68c\uc6a9\ud488 \ubc0f \uc18c\ubaa8\ud488<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc2dc\uc220\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud608\uc7a5\ubd84\ub9ac\uc220<\/li>\n<li class=\"toc-level-3\">5.2.2 \ud608\uc18c\ud310\ubd84\ub9ac\uc220<\/li>\n<li class=\"toc-level-3\">5.2.3 \ubc31\ud608\uad6c\ubd84\ub9ac\uc220<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc801\ud608\uad6c\ubd84\ub9ac\uc220<\/li>\n<li class=\"toc-level-3\">5.2.5 \uad11\ubd84\ub9ac\uc220<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ud608\uc561 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc2e0\uacbd \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc2e0\uc7a5 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc790\uac00\uba74\uc5ed \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.3.5 \uae30\ud0c0 \uc801\uc6a9 \ubd84\uc57c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ud608\uc561 \uc740\ud589 \ubc0f \ud608\uc561 \uc131\ubd84 \uacf5\uae09\uc5c5\uccb4<\/li>\n<li class=\"toc-level-3\">5.4.2 \ubcd1\uc6d0 \ubc0f \uc218\ud608 \uc13c\ud130<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc678\ub798 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Asahi Kasei Corporation<\/li>\n<li class=\"toc-level-3\">6.3.2 B. Braun SE<\/li>\n<li class=\"toc-level-3\">6.3.3 Baxter International Inc.<\/li>\n<li class=\"toc-level-3\">6.3.4 Bioelettronica<\/li>\n<li class=\"toc-level-3\">6.3.5 Cerus Corporation<\/li>\n<li class=\"toc-level-3\">6.3.6 Fresenius SE &amp; Co. KGaA<\/li>\n<li class=\"toc-level-3\">6.3.7 Grifols S.A.<\/li>\n<li class=\"toc-level-3\">6.3.8 Haemonetics Corporation<\/li>\n<li class=\"toc-level-3\">6.3.9 HemaCare Corporation<\/li>\n<li class=\"toc-level-3\">6.3.10 Infomed SA<\/li>\n<li class=\"toc-level-3\">6.3.11 Kaneka Corporation<\/li>\n<li class=\"toc-level-3\">6.3.12 Kawasumi Laboratories Inc.<\/li>\n<li class=\"toc-level-3\">6.3.13 Macopharma SA<\/li>\n<li class=\"toc-level-3\">6.3.14 Mallinckrodt plc<\/li>\n<li class=\"toc-level-3\">6.3.15 Medica S.p.A.<\/li>\n<li class=\"toc-level-3\">6.3.16 Miltenyi Biotec GmbH<\/li>\n<li class=\"toc-level-3\">6.3.17 Nikkiso Co., Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.18 Sumitomo Bakelite Co. Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.19 Terumo Corporation<\/li>\n<li class=\"toc-level-3\">6.3.20 Therakos (Mallinckrodt)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031)<\/p>\n<p># \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \ud1b5\uacc4<\/p>\n<p>\ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220(Apheresis) \uc2dc\uc7a5\uc740 2025\ub144 39\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 41\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud558\uace0, 2031\ub144\uc5d0\ub294 54\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 5.67%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc73c\ub85c \uc608\uce21\ub418\uba70, \ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud560 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p># \uc2dc\uc7a5 \ubd84\uc11d \ubc0f \uc8fc\uc694 \ub3d9\ud5a5<\/p>\n<p>\ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2dc\uc7a5\uc740 \uc218\ud608 \uc758\ud559\uc744 \ub118\uc5b4 CAR-T \uc138\ud3ec \uce58\ub8cc\uc81c\uc640 \uac19\uc740 \ucca8\ub2e8 \uce58\ub8cc\ubc95\uc758 \ud544\uc218\uc801\uc778 \uad6c\uc131 \uc694\uc18c\ub85c \uc790\ub9ac\ub9e4\uae40\ud558\uba70 \uc218\uc694\uac00 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubaa8\ub4e0 FDA \uc2b9\uc778 CAR-T \uc81c\ud488\uc774 \ud45c\uc900\ud654\ub41c \ubc31\ud608\uad6c\ubd84\ub9ac\ubc18\ucd9c\uc220(Leukapheresis)\uc5d0 \uc758\uc874\ud568\uc5d0 \ub530\ub77c, \uc774 \uc2dc\uc220\uc740 \ubc18\ubcf5\uc801\uc778 \uc758\uc57d\ud488 \ud22c\uc785\uc73c\ub85c \uc804\ud658\ub418\uc5b4 \ubcd1\uc6d0\ub4e4\uc774 \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2dc\uc124\uc744 \ud575\uc2ec \uc885\uc591\ud559 \uc778\ud504\ub77c\ub85c \uac04\uc8fc\ud558\uac8c \ub418\uc5c8\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc77c\ud68c\uc6a9 \ud0a4\ud2b8\ub294 \uc2dc\uc220\ub2f9 \ube44\uc6a9\uc744 \uc99d\uac00\uc2dc\ud0a4\uc9c0\ub9cc \ubb3c\uacfc \uc5d0\ub108\uc9c0 \uc18c\ube44\ub97c \uc904\uc5ec \uc870\ub2ec \uc6b0\uc120\uc21c\uc704\uac00 \ub418\uace0 \uc788\uc73c\uba70, \uc790\ub3d9\ud654\ub41c \ub9c9 \uc2dc\uc2a4\ud15c\uc740 \uc2dc\uc220 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \uc138\ud3ec \uc218\uc728\uc744 \ud5a5\uc0c1\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubd81\ubbf8\uc640 \uc720\ub7fd\uc758 \ud608\uc7a5 \uc720\ub798 \uba74\uc5ed\uae00\ub85c\ubd88\ub9b0 \ubd80\uc871\uc740 \ud608\uc7a5\ubd84\ub9ac\ubc18\ucd9c\uc220(Plasmapheresis) \uc218\uc694\ub97c \uc9c0\uc18d\uc801\uc73c\ub85c \ub192\uc774\uace0 \uc788\uc73c\uba70, \uc911\uad6d\uacfc \uc77c\ubcf8\uc758 \uaddc\uc81c \uc2e0\uc18d \uc2b9\uc778\uc740 \uc9c0\uc5ed \uc790\uae09\uc790\uc871 \ud504\ub85c\uadf8\ub7a8\uc744 \uc9c0\uc6d0\ud558\ub294 \uc7a5\ube44 \uc2b9\uc778\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub3c5\uc810\uc801\uc778 \uc77c\ud68c\uc6a9\ud488\uc774 \uad6c\ub9e4\uc790\ub4e4\uc744 \uae30\uc874 \uacf5\uae09\uc5c5\uccb4 \uc0dd\ud0dc\uacc4\uc5d0 \ubb36\uc5b4\ub450\ub294 \ubc18\uba74, \uc911\uad6d \uc911\uacac \uae30\uc5c5\ub4e4\uc774 \uc7a5\ube44 \uac00\uaca9\uc744 \ub0ae\ucd94\uba74\uc11c \uacbd\uc7c1 \uac15\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d:<\/p>\n<p>*   \uc81c\ud488\ubcc4: 2025\ub144 \uc7a5\ube44(Devices)\uac00 \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 67.43%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc77c\ud68c\uc6a9\ud488 \ubc0f \uc18c\ubaa8\ud488(Disposables &#038; Consumables)\uc740 2031\ub144\uae4c\uc9c0 7.24%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc2dc\uc220\ubcc4: 2025\ub144 \ud608\uc7a5\ubd84\ub9ac\ubc18\ucd9c\uc220(Plasmapheresis)\uc774 \uc804\uccb4 \uc2dc\uc220\ub7c9\uc758 41.62%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uad11\ubd84\ub9ac\ubc18\ucd9c\uc220(Photopheresis)\uc740 2031\ub144\uae4c\uc9c0 8.35%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc801\uc6a9 \ubd84\uc57c\ubcc4: 2025\ub144 \ud608\uc561 \uc9c8\ud658(Hematological Disorders)\uc774 \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2dc\uc7a5\uc758 37.88%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc2e0\uacbd\ud559\uc801 \uc9c8\ud658(Neurological Disorders)\uc740 2031\ub144\uae4c\uc9c0 6.85%\uc758 CAGR\ub85c \ud655\ub300\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: 2025\ub144 \ubcd1\uc6d0 \ubc0f \uc218\ud608 \uc13c\ud130(Hospitals &#038; Transfusion Centers)\uac00 47.74%\uc758 \ub9e4\ucd9c \uc810\uc720\uc728\ub85c \uc120\ub450\ub97c \ub2ec\ub838\uc73c\uba70, \ud608\uc561\uc6d0 \ubc0f \ud608\uc561 \uc131\ubd84 \uacf5\uae09\uc790(Blood Banks &#038; Component Providers)\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 8.68%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: 2025\ub144 \ubd81\ubbf8(North America)\uac00 43.35%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(Asia-Pacific) \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 8.08%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p># \uae00\ub85c\ubc8c \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>\uc131\uc7a5 \ub3d9\uc778:<\/p>\n<p>*   \ud608\uc561\ud559\uc801 \ubc0f \uc790\uac00\uba74\uc5ed \uc9c8\ud658 \uc720\ubcd1\ub960 \uc99d\uac00 (+1.2% CAGR \uc601\ud5a5): 2024-2025\ub144 \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \ub300\uc0c1 \uc0ac\ub840\uac00 18% \uc99d\uac00\ud588\uc73c\uba70, \ud2b9\ud788 \ub2e4\ubc1c\uc131 \uace8\uc218\uc885, \ud615\uc9c8\uc138\ud3ec \uc774\uc0c1\uc99d, \uc911\uc99d \uadfc\ubb34\ub825\uc99d, \ub9cc\uc131 \uc5fc\uc99d\uc131 \ud0c8\uc218\ucd08\uc131 \ub2e4\ubc1c\uc131 \uc2e0\uacbd\ubcd1\uc99d \uc9c4\ub2e8\uc774 \ub298\uc5b4 \uce58\ub8cc\uc801 \ud608\uc7a5 \uad50\ud658\uc220\uc774 1\ucc28 \uce58\ub8cc\ubc95\uc73c\ub85c \uc790\ub9ac \uc7a1\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uc5d0\uc11c\ub294 \uba74\uc5ed\ud761\ucc29 \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2b9\uc778 \ud6c4 \uc804\uc2e0\uc131 \ud64d\ubc18\uc131 \ub8e8\ud478\uc2a4 \ud658\uc790 14,000\uba85\uc774 \ucd94\uac00\ub85c \ubcf4\ud5d8 \ud61c\ud0dd\uc744 \ubc1b\uac8c \ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uace0\ub839\ud654\ub294 \ub2e8\uc77c\ud074\ub860 \uac10\ub9c8\ubcd1\uc99d \ubc1c\uc0dd\ub960\uc744 \ub192\uc5ec \uc2dc\uc220\ub7c9 \uc99d\uac00\uc5d0 \uae30\uc5ec\ud569\ub2c8\ub2e4.<br \/>\n*   \ud608\uc7a5 \uc720\ub798 \uce58\ub8cc\uc81c \ubc0f \ud608\uc561 \uc131\ubd84 \uc218\uc694 \uc99d\uac00 (+0.8% CAGR \uc601\ud5a5): 2025\ub144 \uba74\uc5ed\uae00\ub85c\ubd88\ub9b0 \uc18c\ube44\uac00 7.8% \uc99d\uac00\ud558\uc5ec \uc804\ud608 \uae30\uc99d\uc744 \ub118\uc5b4\uc130\uace0, \ud608\uc561\uc6d0\ub4e4\uc758 \uace0\ucc98\ub9ac\ub7c9 \ud608\uc7a5\ubd84\ub9ac\ubc18\ucd9c\uc220 \uc7a5\ube44 \ud22c\uc790\ub85c \uc774\uc5b4\uc84c\uc2b5\ub2c8\ub2e4. \uadf8\ub9ac\ud3f4\uc2a4(Grifols)\ub294 \ubbf8\uad6d \ub0b4 14\uac1c \ud608\uc7a5 \uc13c\ud130\ub97c \ucd94\uac00\ud558\uace0 \ucc44\uc9d1\ub7c9\uc774 9.2% \uc99d\uac00\ud588\ub2e4\uace0 \ubcf4\uace0\ud588\uc2b5\ub2c8\ub2e4. CMS\ub294 \uc2a4\ud14c\ub85c\uc774\ub4dc \ubd88\uc751\uc131 \uc774\uc2dd\ud3b8\ub300\uc219\uc8fc\ubcd1(GVHD) \uad11\ubd84\ub9ac\ubc18\ucd9c\uc220\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc801\uc6a9\uc744 \ud655\ub300\ud558\uc5ec \uc5f0\uac04 1\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc0c1\ud658 \uc2dc\uc7a5\uc744 \ud615\uc131\ud588\uc2b5\ub2c8\ub2e4. \uc911\uad6d\uc758 14\uac1c \uc2e0\uaddc \uc7a5\ube44 \ubaa8\ub378 \uc2b9\uc778\uacfc \uc778\ub3c4\uc758 \uc0dd\uc0b0 \ub2a5\ub825 \ub450 \ubc30 \uc99d\ub300 \uacc4\ud68d\uc740 \uc2e0\ud765 \uc2dc\uc7a5\uc774 \uc218\uc785 \uc758\uc874\ub3c4\ub97c \uc904\uc774\uae30 \uc704\ud574 \ud608\uc7a5 \uacf5\uae09\uc744 \ud604\uc9c0\ud654\ud558\uace0 \uc788\uc74c\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<br \/>\n*   \uc790\ub3d9\ud654 \ubc0f \ub9c9 \uc5ec\uacfc \uae30\uc220 \ubc1c\uc804 (+1.5% CAGR \uc601\ud5a5): \ud504\ub808\uc81c\ub2c8\uc6b0\uc2a4 \uce74\ube44(Fresenius Kabi)\uc758 Lovo \uc2dc\uc2a4\ud15c\uc740 \uad11\ud559 \ud5e4\ub9c8\ud1a0\ud06c\ub9ac\ud2b8 \uc13c\uc11c\ub97c \ub3c4\uc785\ud558\uc5ec \uc800\uce7c\uc298\ud608\uc99d \ubc1c\uc0dd\uc744 34% \uac10\uc18c\uc2dc\ucf30\uace0, \uc774\ub294 \uc6b4\uc601\uc790 \uac10\ub3c5 \uc694\uad6c \uc0ac\ud56d\uc744 \uc904\uc5ec \uc9c0\uc5ed \ubcd1\uc6d0\uc5d0\uc11c\uc758 \ucc44\ud0dd\uc744 \ud655\ub300\ud588\uc2b5\ub2c8\ub2e4. FDA \uc2b9\uc778\uc744 \ubc1b\uc740 Aurora Xi \ubd84\ub9ac\uae30\ub294 0.2\ub9c8\uc774\ud06c\ub860 \uc911\uacf5\uc0ac\ub9c9\uc744 \uc0ac\uc6a9\ud558\uc5ec \uc6d0\uc2ec\ubd84\ub9ac\uc640 \uad00\ub828\ub41c \ud608\uc18c\ud310 \uc190\uc0c1\uc744 \ucd5c\uc18c\ud654\ud558\uace0 \ub2e8\uc77c \uacf5\uc5ec\uc790 \ud608\uc18c\ud310 \uc218\uc728\uc744 \ucd5c\ub300 22% \uc99d\uac00\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \ud14c\ub8e8\ubaa8 BCT(Terumo BCT)\ub294 2025\ub144 \uc911\ubc18 Spectra Optia\uc5d0 \uc804\uc790\uc758\ubb34\uae30\ub85d(EHR) \uc5f0\ub3d9 \uae30\ub2a5\uc744 \ud1b5\ud569\ud558\uc5ec \ud658\uc790 \ub9e4\uac1c\ubcc0\uc218\ub97c \uc790\ub3d9\uc73c\ub85c \ucc44\uc6b0\uace0 6\uac1c \uac80\uc99d \uc0ac\uc774\ud2b8\uc5d0\uc11c \uc124\uc815 \uc624\ub958\ub97c 41% \uac10\uc18c\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uae30\uc220 \ubc1c\uc804\uc740 \uad50\uc721 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \uc548\uc804\uc131\uc744 \ud5a5\uc0c1\uc2dc\ud0a4\uba70 \uc2dc\uc124 \ud68c\uc804\uc728\uc744 \ub192\uc5ec \uc7a5\ube44 \uad50\uccb4 \uc8fc\uae30\ub97c \uac00\uc18d\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \ubc31\ud608\uad6c\ubd84\ub9ac\ubc18\ucd9c\uc220\uc744 \ud544\uc694\ub85c \ud558\ub294 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \ud655\ub300 (+1.8% CAGR \uc601\ud5a5): 2024-2025\ub144\uc5d0 \uc2b9\uc778\ub41c 7\uac1c\uc758 CAR-T \uce58\ub8cc\uc81c\ub294 \uc790\uac00 \ubc31\ud608\uad6c\ubd84\ub9ac\ubc18\ucd9c\uc220\uc744 \ud544\uc694\ub85c \ud558\uba70, \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc791\uc5c5 \uacf5\uac04\uc744 \uc138\ud3ec \uce58\ub8cc \uacf5\uae09\ub9dd\uc758 \ud544\uc218 \ub178\ub4dc\ub85c \uc804\ud658\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \ud504\ub85c\ud1a0\ucf5c \ucd5c\uc801\ud654\ub85c CD3+ \uc138\ud3ec \ud68c\uc218\uc728\uc774 11%p \uc99d\uac00\ud558\uba74\uc11c YESCARTA\uc758 \ub9ac\ub4dc \ud0c0\uc784\uc774 \ub2e8\ucd95\ub418\uc5c8\uace0, ABECMA\ub294 \uc678\ub798 \ubc31\ud608\uad6c\ubd84\ub9ac\ubc18\ucd9c\uc220\uc744 \ud5c8\uc6a9\ud558\uc5ec \ubcd1\uc0c1 \ud65c\uc6a9\ub3c4\ub97c \uc904\uc774\uace0 \uc9c1\uc811 \ube44\uc6a9\uc744 \uc808\uac10\ud588\uc2b5\ub2c8\ub2e4. KYMRIAH \ucc44\uc9d1\ub7c9\uc740 \uc804\ub144 \ub300\ube44 31% \uc99d\uac00\ud588\uc73c\uba70, \uc2dc\uc220\uc758 42%\uac00 \uc9c0\uc5ed \uc885\uc591\ud559 \uc2dc\uc124\ub85c \uc774\uc804\ub418\uc5b4 \uc911\uacac \ubd84\ub9ac\uae30 \uc2dc\uc7a5\uc774 \ud655\ub300\ub418\uc5c8\uc2b5\ub2c8\ub2e4. 18\uac1c\uc758 CAR-T \ud6c4\ubcf4 \ubb3c\uc9c8\uc774 3\uc0c1 \uc784\uc0c1 \uc911\uc774\ubbc0\ub85c, \ubc31\ud608\uad6c\ubd84\ub9ac\ubc18\ucd9c\uc220 \uc218\uc694\ub294 2028\ub144\uae4c\uc9c0 \ub450 \uc790\ub9bf\uc218 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uba70 \uc18c\ubaa8\ud488\uc5d0 \ub300\ud55c \ubc18\ubcf5\uc801\uc778 \uc218\uc694\ub97c \uacf5\uace0\ud788 \ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ud734\ub300\uc6a9 \ud604\uc7a5 \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2dc\uc2a4\ud15c\uc758 \ub4f1\uc7a5 (+0.5% CAGR \uc601\ud5a5): \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \ub18d\ucd0c \uc9c0\uc5ed, \uc0ac\ud558\ub77c \uc774\ub0a8 \uc544\ud504\ub9ac\uce74, \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74 \ub4f1\uc5d0\uc11c \ud734\ub300\uc6a9 \uc2dc\uc2a4\ud15c\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   ESG \uc8fc\ub3c4 \uc800\ud3d0\uae30\ubb3c \uc77c\ud68c\uc6a9 \ud0a4\ud2b8 \ud22c\uc790 (+0.9% CAGR \uc601\ud5a5): \ubd81\ubbf8 \ubc0f EU \uc9c0\uc5ed, \ud2b9\ud788 \uce98\ub9ac\ud3ec\ub2c8\uc544\uc640 \ub3c5\uc77c\uc758 \uaddc\uc81c \uac15\ud654\ub85c \uc800\ud3d0\uae30\ubb3c \uc77c\ud68c\uc6a9 \ud0a4\ud2b8\uc5d0 \ub300\ud55c \ud22c\uc790\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc81c\uc57d \uc694\uc778:<\/p>\n<p>*   \ub192\uc740 \uc7a5\ube44 \ubc0f \uc18c\ubaa8\ud488 \ube44\uc6a9 (-1.1% CAGR \uc601\ud5a5): \uc790\ub3d9 \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc7a5\ube44\ub294 85,000~140,000 USD\uc5d0 \ub2ec\ud558\uba70, 200\ud68c \uc2dc\uc220 \uc2dc\uc124\uc740 \uc5f0\uac04 180,000~260,000 USD\ub97c \uc18c\ubaa8\ud488\uc5d0 \uc9c0\ucd9c\ud569\ub2c8\ub2e4. 2025\ub144 CMS\uc758 \ubcd1\uc6d0 \uc678\ub798 \ud608\uc7a5 \uad50\ud658\uc220 \uc218\uac00 18% \uc778\ud558\ub85c \uc218\uc775 \ub9c8\uc9c4\uc774 \uc904\uc5b4 \uc2e0\uaddc \uc7a5\ube44 \uc8fc\ubb38\uc774 \uc704\ucd95\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uacf5\uae09\uc5c5\uccb4 \uae08\uc735 \ub9ac\uc2a4 \ubc0f \uc2dc\uc57d \uc784\ub300 \ubaa8\ub378\uc774 \ub4f1\uc7a5\ud588\uc9c0\ub9cc, \ubcd1\uc6d0\ub4e4\uc774 \uacf5\uae09 \uc911\ub2e8 \uc2dc \uc18c\ubaa8\ud488\uc5d0 \ubb36\uc774\ub294 \uac83\uc744 \uc6b0\ub824\ud558\uc5ec \ucc44\ud0dd\uc774 \ubbf8\uc628\uc801\uc785\ub2c8\ub2e4.<br \/>\n*   \uc219\ub828\ub41c \uc804\ubb38\uac00 \ubd80\uc871 (-0.8% CAGR \uc601\ud5a5): \ubbf8\uad6d \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \ud559\ud68c(American Society for Apheresis)\uc5d0 \ub530\ub974\uba74 2025\ub144 \ubbf8\uad6d \ubcd1\uc6d0\uc758 38%\uac00 \uacf5\uc778 \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc804\ubb38\uac00 \ucc44\uc6a9\uc5d0 \uc5b4\ub824\uc6c0\uc744 \uacaa\uc5c8\uc73c\uba70, \uc774\ub294 2\ub144 \uc804 29%\uc5d0\uc11c \uc99d\uac00\ud55c \uc218\uce58\uc785\ub2c8\ub2e4. \uc720\ub7fd\uc740 2024\ub144 120\uc2dc\uac04 \uac04\ud638\uc0ac \uad50\uc721 \uc778\uc99d\uc11c\ub97c \ub3c4\uc785\ud588\uc9c0\ub9cc, \uc2e0\uaddc \uc124\uce58\uc758 15% \ubbf8\ub9cc\uc744 \ucda9\uc871\ud558\ub294 340\uba85\ub9cc\uc774 \ucde8\ub4dd\ud588\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uc740 CAR-T \ucc44\uc9d1 \uc5ed\ub7c9\uc744 \ucd94\uad6c\ud558\ub294 \ud604\uc5d0\uc11c 420\uba85\uc758 \uc778\ub825 \ubd80\uc871\uc5d0 \uc9c1\uba74\ud574 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud575\uc2ec \uc77c\ud68c\uc6a9\ud488 \uacf5\uae09\ub9dd \uc704\ud5d8 (-0.6% CAGR \uc601\ud5a5): \ub2e8\uc77c \uacf5\uae09\uc5c5\uccb4\uc5d0 \uc758\uc874\ud558\ub294 \uc9c0\uc5ed\uc5d0\uc11c \uacf5\uae09\ub9dd \uc704\ud5d8\uc774 \uace0\uc870\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubcd1\uc6d0\uccb4 \uac10\uc18c \uc804\ud608 \uae30\uc220\uacfc\uc758 \uacbd\uc7c1 (-0.4% CAGR \uc601\ud5a5): \ubd81\ubbf8 \ubc0f EU \uc9c0\uc5ed\uc5d0\uc11c \ubcd1\uc6d0\uccb4 \uac10\uc18c \uc804\ud608 \uae30\uc220\uacfc\uc758 \uacbd\uc7c1\uc774 \uc874\uc7ac\ud558\uc9c0\ub9cc, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \ubc0f \uc911\ub3d9 \uc544\ud504\ub9ac\uce74 \uc9c0\uc5ed\uc5d0\uc11c\ub294 \uc601\ud5a5\uc774 \uc81c\ud55c\uc801\uc785\ub2c8\ub2e4.<\/p>\n<p># \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>\uc81c\ud488\ubcc4:<br \/>\n2025\ub144 \uc7a5\ube44 \ubd80\ubb38\uc774 67.43%\uc758 \uac00\uce58 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud588\uc9c0\ub9cc, \uc77c\ud68c\uc6a9\ud488 \ubc0f \uc18c\ubaa8\ud488\uc740 2031\ub144\uae4c\uc9c0 7.24%\uc758 CAGR\ub85c \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2dc\uc7a5\uc744 \ub2a5\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc0b4\uade0 \ub2e8\uacc4\ub97c \uc5c6\uc560\uace0 ESG \uc758\ubb34\uc5d0 \ubd80\ud569\ud558\ub294 \uc77c\ud68c\uc6a9 \ud0a4\ud2b8\uc758 \ud655\uc0b0\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. Amicus \ud3d0\uc1c4 \ub8e8\ud504 \uc138\ud2b8\ub97c \ucc44\ud0dd\ud55c \ubcd1\uc6d0\ub4e4\uc740 \uc124\uc815 \uc2dc\uac04\uc744 9\ubd84 \ub2e8\ucd95\ud558\uace0 \uc624\uc5fc \uc704\ud5d8\uc744 62% \uc904\uc5ec 40%\uc758 \ub9e4\ucd9c \ucd1d\uc774\uc775\uc744 \uac00\uc9c4 \uc18c\ubaa8\ud488 \ud750\ub984\uc744 \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4. \ub3d9\uc2dc\uc5d0 \uc911\uad6d \uae30\uc5c5\ub4e4\uc774 \uae30\uc874 \uc5c5\uccb4\ubcf4\ub2e4 22~28% \ub0ae\uc740 \uac00\uaca9\uc73c\ub85c \uc81c\ud488\uc744 \ucd9c\uc2dc\ud558\uba74\uc11c \uc7a5\ube44 \ud3c9\uade0 \ud310\ub9e4 \uac00\uaca9\uc740 4.3% \ud558\ub77d\ud558\uc5ec \ub3c5\uc810 \uc18c\ubaa8\ud488\uc73c\ub85c\uc758 \ub9c8\uc9c4 \uc774\ub3d9\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. CAR-T \ucc44\uc9d1 \uc13c\ud130\ub294 \uccb4\uc778 \uc624\ube0c \uc544\uc774\ub374\ud2f0\ud2f0(chain-of-identity) \uac10\uc0ac \uc694\uad6c \uc0ac\ud56d\uc744 \ucda9\uc871\ud558\uae30 \uc704\ud574 EHR \ud1b5\ud569 \uc790\ub3d9\ud654\uac00 \ud544\uc694\ud558\ubbc0\ub85c \uc7a5\ube44 \uad50\uccb4 \uc8fc\uae30\ub294 \uc5ec\uc804\ud788 \uc911\uc694\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc220\ubcc4:<br \/>\n2025\ub144 \ud608\uc7a5\ubd84\ub9ac\ubc18\ucd9c\uc220\uc774 \ub9cc\uc131 \uba74\uc5ed\uae00\ub85c\ubd88\ub9b0 \ub300\uccb4 \ubc0f \uc2e0\uacbd\ud559\uc801 \ud608\uc7a5 \uad50\ud658 \uc801\uc751\uc99d\uc744 \ubc18\uc601\ud558\uc5ec \uc2dc\uc220\uc758 41.62%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uad11\ubd84\ub9ac\ubc18\ucd9c\uc220\uc740 FDA \uc2b9\uc778 CELLEX \uc2dc\uc2a4\ud15c\uc5d0 \ud798\uc785\uc5b4 8.35%\uc758 CAGR\ub85c \ud655\ub300\ub418\uace0 \uc788\uc73c\uba70, \uc774 \uc2dc\uc2a4\ud15c\uc740 \uc2dc\uc220 \uc2dc\uac04\uc744 3\uc2dc\uac04\uc73c\ub85c \ub2e8\ucd95\ud558\uace0 \uc18c\uc544 GVHD\uc5d0 \ub300\ud55c \uad11\ubc94\uc704\ud55c CMS \ubcf4\ud5d8 \uc801\uc6a9\uc744 \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4. \ud608\uc18c\ud310\ubd84\ub9ac\ubc18\ucd9c\uc220\uc740 \ud608\uc561\uc6d0 \ubb3c\ub958\uc5d0 \ud544\uc218\uc801\uc774\uba70, \ubc31\ud608\uad6c\ubd84\ub9ac\ubc18\ucd9c\uc220\uc740 CAR-T \uce58\ub8cc\uc81c \ucd9c\uc2dc\uc640 \ud568\uaed8 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc801\ud608\uad6c\ubd84\ub9ac\ubc18\ucd9c\uc220\uc740 \uc0ac\ud558\ub77c \uc774\ub0a8 \uc544\ud504\ub9ac\uce74\uc5d0\uc11c \uacb8\uc0c1 \uc801\ud608\uad6c \uc9c8\ud658 \uc2dc\uc220\uc758 54%\uac00 \uc5ec\uc804\ud788 \uc218\ub3d9 \uad50\ud658\uc73c\ub85c \uc774\ub8e8\uc5b4\uc9c0\uace0 \uc790\ub3d9\ud654 \uc7a5\ube44\uac00 \ubd80\uc871\ud558\uc5ec 4.1%\uc758 \uc644\ub9cc\ud55c \uc131\uc7a5\uc744 \ubcf4\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc801\uc6a9 \ubd84\uc57c\ubcc4:<br \/>\n2025\ub144 \ud608\uc561\ud559\uc801 \uc801\uc751\uc99d\uc774 \ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 37.88%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc911\uc99d \uadfc\ubb34\ub825\uc99d \ubc0f \uae38\ub7ad-\ubc14\ub808 \uc99d\ud6c4\uad70\uc5d0 \ub300\ud55c \ud608\uc7a5 \uad50\ud658\uc220\uc758 1\ucc28 \uce58\ub8cc\ubc95 \uc9c0\uc704\uac00 \uc2dc\uc220 \ube48\ub3c4\ub97c \ub192\uc774\uba74\uc11c \uc2e0\uacbd\ud559\uc801 \uc9c8\ud658\uc740 6.85%\uc758 CAGR\ub85c \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uace0\ub839\ud654\uc640 \uac1c\uc120\ub41c \uc790\uac00\ud56d\uccb4 \uac80\uc0ac\ub294 \uc9c4\ub2e8\uc728\uc744 \ub192\uc5ec \uc9c0\uc18d\uc801\uc778 \ud65c\uc6a9\uc744 \ubcf4\uc7a5\ud569\ub2c8\ub2e4. \ub780\uc14b \uc2e0\uacbd\ud559(Lancet Neurology) \uba54\ud0c0 \ubd84\uc11d\uc5d0 \ub530\ub974\uba74 \uaca9\uc8fc \ud608\uc7a5 \uad50\ud658\uc220\uc774 \uc7a5\uc560 \uc9c4\ud589\uc744 41% \uac10\uc18c\uc2dc\ucf1c \uc774 \uce58\ub8cc\ubc95\uc758 \uc815\ub2f9\uc131\uc744 \ub354\uc6b1 \uac15\ud654\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4:<br \/>\n2025\ub144 \ubcd1\uc6d0\uc774 47.74%\uc758 \ub9e4\ucd9c \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud588\uc9c0\ub9cc, \ud608\uc561\uc6d0\uc740 \uace0\ub839\ud654 \uc778\uad6c\ub85c \uc778\ud55c \ud608\uc7a5 \ub2e8\ubc31\uc9c8 \uce58\ub8cc\uc81c \uc218\uc694 \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 8.68%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. Haemonetics\uc758 MCS+\ub97c \ucc44\ud0dd\ud55c \ubbf8\uad6d \ud608\uc561 \uc13c\ud130\ub294 \uc218\uc728\uc774 22% \uc99d\uac00\ud558\uace0 \uacf5\uc5ec\uc790 \ub300\uae30 \uc2dc\uac04\uc744 14\ubd84 \ub2e8\ucd95\ud558\uc5ec \uc7a5\ube44 \uad6c\ub9e4\ub97c \uc815\ub2f9\ud654\ud558\ub294 \uc6b4\uc601 \ud6a8\uc728\uc131\uc744 \ubcf4\uc5ec\uc8fc\uc5c8\uc2b5\ub2c8\ub2e4. \uc678\ub798 \uc9c4\ub8cc\uc18c\ub294 CMS\uc758 \ud604\uc7a5 \uc911\ub9bd \uc9c0\ubd88 \uc0ad\uac10\uc73c\ub85c \ub9cc\uc131 \ud608\uc7a5 \uad50\ud658\uc220\uc774 \ubcd1\uc6d0 \uc678\ub798 \ud658\uacbd\uc5d0\uc11c \ubc97\uc5b4\ub098\uba74\uc11c \ub9e4\ucd9c\uc758 14.3%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p># \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 43.35%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\ub85c \uc120\ub450\ub97c \ub2ec\ub838\uc73c\uba70, 4,200\uac1c\uc758 \uc7a5\ube44\uac00 \uce58\ub8cc, \ud608\uc561\uc6d0, CAR-T \ucc44\uc9d1 \uc218\uc694\ub97c \ucda9\uc871\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. CMS \uc678\ub798 \uc218\uac00 \uc0ad\uac10\uc73c\ub85c \ud608\uc7a5 \uad50\ud658\uc220 \uc218\uc694\uac00 \uc678\ub798 \uc9c4\ub8cc\uc18c\ub85c \uc804\ud658\ub418\uc5b4 \uac04\uc811\ube44\uac00 32% \uac10\uc18c\ud558\uace0 \uc18c\ud615\uc758 \uae30\uc220\uc790 \uce5c\ud654\uc801\uc778 \uc2dc\uc2a4\ud15c\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4. \uce90\ub098\ub2e4\uc758 9\uac1c \uc2e0\uaddc \ud608\uc7a5 \uc13c\ud130\ub294 \uc218\uc785 \uc758\uc874\ub3c4\ub97c 14% \uc904\uc5ec PCS2 \uc7a5\ube44 \ud310\ub9e4\ub97c 19% \uc99d\uac00\uc2dc\ucf30\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: CliniMACS Prodigy\uc758 EMA \uc2b9\uc778\uc73c\ub85c 18\uac1c \uc0ac\uc774\ud2b8\uc5d0\uc11c \ubd84\uc0b0\ud615 CAR-T \ucc98\ub9ac\uac00 \uac00\ub2a5\ud574\uc838 \ud658\uc790\ub2f9 \ubb3c\ub958 \ube44\uc6a9\uc774 12,000\uc720\ub85c \uc808\uac10\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \ub3c5\uc77c\uc740 \uc2a4\ud14c\ub85c\uc774\ub4dc \ubd88\uc751\uc131 GVHD\uc5d0 \ub300\ud55c \uad11\ubd84\ub9ac\ubc18\ucd9c\uc220\uc5d0 \ubcf4\ud5d8\uc744 \uc801\uc6a9\ud558\uc5ec 1,600\uba85\uc758 \ud658\uc790\ub97c \ucd94\uac00\ud558\uace0 CELLEX \uc124\uce58\ub97c \ucd09\uc9c4\ud588\uc2b5\ub2c8\ub2e4. \uc601\uad6d\uc740 14\uac1c \uc9c0\uc5ed\uc5d0 Trima Accel\uc744 \ucd9c\uc2dc\ud55c \ud6c4 \ud608\uc18c\ud310\ubd84\ub9ac\ubc18\ucd9c\uc220\uc744 6.8% \uc99d\uac00\uc2dc\ucf30\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 8.08%\uc758 CAGR\ub85c \uc804 \uc138\uacc4\uc5d0\uc11c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc911\uad6d\uc740 14\uac1c \uc7a5\ube44 \ubaa8\ub378\uc744 \uc2b9\uc778\ud558\uace0 2024\ub144 \ud608\uc7a5 \ubd84\ud68d \uc6a9\ub7c9\uc744 18% \ub298\ub824 \uc218\uc785 \uc81c\uc57d\uc5d0 \ub300\ube44\ud588\uc2b5\ub2c8\ub2e4. \uc778\ub3c4\ub294 2027\ub144\uae4c\uc9c0 \ucc44\uc9d1 \uc13c\ud130 \uc218\ub97c \ub450 \ubc30\ub85c \ub298\ub9ac\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c Fresenius Kabi\uc640 Haemonetics\ub85c\ubd80\ud130 80\uac1c\uc758 \uc7a5\ube44\ub97c \uc8fc\ubb38\ud588\uc9c0\ub9cc, \ub8e8\ud53c\ud654 \uc57d\uc138\uac00 \uac00\uaca9 \uacbd\uc7c1\ub825\uc744 \uc800\ud574\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uc758 \uace0\ub839\ud654 \uc778\uad6c\ub294 \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc5d0 \ub300\ud55c \ud608\uc7a5\ubd84\ub9ac\ubc18\ucd9c\uc220\uc744 12% \uc99d\uac00\uc2dc\ucf30\uc9c0\ub9cc, 420\uba85\uc758 \uc219\ub828\ub41c \uc778\ub825 \ubd80\uc871\uc774 \ub18d\ucd0c \ud655\uc7a5\uc744 \uc800\ud574\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74: \ub9e4\ucd9c\uc758 6.2%\ub97c \ucc28\uc9c0\ud558\uba70, GCC \uad6d\uac00\ub4e4\uc740 \ud608\uc7a5 \uc790\uae09\uc790\uc871\uc5d0 \ud22c\uc790\ud558\uace0 \ub0a8\uc544\ud504\ub9ac\uce74\ub294 \ud608\uc18c\ud310\ubd84\ub9ac\ubc18\ucd9c\uc220\uc744 22% \ud655\ub300\ud588\uc2b5\ub2c8\ub2e4. \uc0ac\ud558\ub77c \uc774\ub0a8 \uc544\ud504\ub9ac\uce74\uc5d0\uc11c\ub294 \uc790\ub3d9\ud654 \uc7a5\ube44\uac00 \ubd80\uc871\ud558\uc5ec \uacb8\uc0c1 \uc801\ud608\uad6c \uc9c8\ud658 \uce58\ub8cc\uc5d0 \uc218\ub3d9 \uc801\ud608\uad6c \uad50\ud658\uc220\uc774 \uc9c0\ubc30\uc801\uc785\ub2c8\ub2e4.<\/p>\n<p># \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\ud608\uc561\uc131\ubd84\ubd84\ub9ac\uc220 \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. \uc0c1\uc704 5\uac1c \uacf5\uae09\uc5c5\uccb4\uac00 2025\ub144 \ucd9c\ud558\ub7c9\uc758 \uc0c1\ub2f9 \ubd80\ubd84\uc744 \ucc28\uc9c0\ud588\uc9c0\ub9cc, \uac1c\ubcc4 \uc810\uc720\uc728\uc774 22%\ub97c \ucd08\uacfc\ud558\ub294 \uc5c5\uccb4\ub294 \uc5c6\uc5c8\uc2b5\ub2c8\ub2e4. \ud504\ub808\uc81c\ub2c8\uc6b0\uc2a4 \uce74\ube44(Fresenius Kabi)\uc758 Amicus \ud50c\ub7ab\ud3fc\uc740 \uc2e4\uc2dc\uac04 \ud5e4\ub9c8\ud1a0\ud06c\ub9ac\ud2b8 \uac10\uc9c0 \ubc0f \uc790\ub3d9 \uad6c\uc5f0\uc0b0\uc5fc \ud22c\uc5ec\ub97c \ud1b5\ud574 240\uba85 \ud658\uc790 \uc5f0\uad6c\uc5d0\uc11c \uc800\uce7c\uc298\ud608\uc99d \ubc1c\uc0dd\uc744 34% \uac10\uc18c\uc2dc\ucf30\uace0, \ubbf8\uad6d\uc5d0\uc11c 19\uac1c\uc758 \uc2e0\uaddc \uacc4\uc57d\uc744 \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4. Haemonetics\ub294 \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74\uc5d0\uc11c \ucd08\uae30 \ube44\uc6a9\uc744 \ub0ae\ucd94\ub294 \uc2dc\uc57d \uc784\ub300 \uae08\uc735\uc73c\ub85c \ub300\uc751\ud558\uc9c0\ub9cc, \ubcd1\uc6d0\ub4e4\uc740 \uc18c\ubaa8\ud488\uc5d0 \ubb36\uc774\ub294 \uac83\uc744 \uacbd\uacc4\ud569\ub2c8\ub2e4. \ud14c\ub8e8\ubaa8 BCT(Terumo BCT)\uc758 EHR \ud1b5\ud569 Spectra Optia\ub294 \uc124\uc815 \uc624\ub958\ub97c 41% \uac10\uc18c\uc2dc\ucf1c \uac10\uc0ac \ucd94\uc801\uc774 \ud544\uc218\uc801\uc778 CAR-T \ucc44\uc9d1 \ud50c\ub7ab\ud3fc\uc73c\ub85c \uc120\ud638\ub429\ub2c8\ub2e4.<\/p>\n<p>\ub18d\ucd0c \uc218\ud608 \uc13c\ud130\ub97c \uc704\ud55c \ud734\ub300\uc6a9 \uc7a5\ube44\uc640 \uacb8\uc0c1 \uc801\ud608\uad6c \uc9c8\ud658 \uce58\ub8cc\ub97c \uc704\ud55c \uc790\ub3d9 \uc801\ud608\uad6c \uad50\ud658\uc220 \ubd84\uc57c\uc5d0\ub294 \uc5ec\uc804\ud788 \ubbf8\uac1c\ucc99 \uc2dc\uc7a5\uc774 \uc874\uc7ac\ud569\ub2c8\ub2e4. Kaneka\uc758 22kg Lifestream \uc7a5\ube44\ub294 \uc774\ub3d9\uc2dd \ucc44\uc9d1\uc744 \ubaa9\ud45c\ub85c \ud558\uba70 4\uac1c\uc6d4 \ub9cc\uc5d0 \uc77c\ubcf8\uc5d0\uc11c 14\uac74\uc758 \uc8fc\ubb38\uc744 \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4. Miltenyi Biotec\uc758 CliniMACS Prodigy\ub294 CAR-T \ucc98\ub9ac\ub97c \ubd84\uc0b0\ud654\ud558\uc5ec \ud658\uc790\ub2f9 18,000~24,000 USD\uc758 \ubb3c\ub958 \ube44\uc6a9\uc744 \uc808\uac10\ud569\ub2c8\ub2e4. \uc911\uad6d \uc790\ud68c\uc0ac\uc778 Jinbao\uc640 Shanghai RAAS\ub294 \uac00\uaca9 \uacbd\uc7c1\ub825\uc744 \ud1b5\ud574 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \ub9e4\ucd9c\uc758 11%\ub97c \ucc28\uc9c0\ud588\uc9c0\ub9cc, \uc81c\ud55c\ub41c FDA \ub610\ub294 CE \ub9c8\ud06c\ub85c \uc778\ud574 \uaddc\uc81c\ub41c OECD \uc2dc\uc7a5\uc5d0\uc11c\uc758 \uce68\ud22c\uac00 \uc81c\ud55c\uc801\uc785\ub2c8\ub2e4. FDA \ud3c9\uade0 9.2\uac1c\uc6d4, EU-MDR \ud3c9\uade0 14\uac1c\uc6d4\uc758 \uaddc\uc81c \uc2b9\uc778 \uae30\uac04\uc740 \uc9c4\uc785 \uc7a5\ubcbd\uc73c\ub85c \uc791\uc6a9\ud558\uc5ec \uae30\uc874 \uc5c5\uccb4\ub4e4\uc758 \uc6b0\uc704\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790:<br \/>\n*   Fresenius SE &#038; Co. KGaA<br \/>\n*   Asahi Kasei Corporation<br \/>\n*   Haemonetics Corporation<br \/>\n*   B. Braun SE<br \/>\n*   Terumo Corporation<\/p>\n<p># \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 5\uc6d4: \ub2e4\ucf00\ub2e4(Takeda)\uc758 BioLife Plasma Services\ub294 \ubbf8\uad6d \ub0b4 \ud608\uc7a5 \uae30\uc99d \uc13c\ud130\uc5d0 \ud504\ub808\uc81c\ub2c8\uc6b0\uc2a4 \uce74\ube44(Fresenius Kabi)\uc758 Adaptive Nomogram\uc744 \ubc30\ud3ec\ud558\uae30 \uc2dc\uc791\ud588\uc2b5\ub2c8\ub2e4. Aurora Xi \ud608\uc7a5\ubd84\ub9ac\ubc18\ucd9c\uc220 \uc2dc\uc2a4\ud15c\uc5d0 \ud1b5\ud569\ub41c \uc774 \uae30\uc220\uc740 \uae30\uc99d \ud6a8\uc728\uc131\uacfc \uc548\uc804\uc131\uc744 \ud5a5\uc0c1\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 1\uc6d4: FDA\ub294 Aurora Xi \uc790\ub3d9 \ud608\uc7a5 \ubd84\ub9ac\uae30\uc5d0 510(k) \uc2b9\uc778\uc744 \ubd80\uc5ec\ud588\uc2b5\ub2c8\ub2e4. \uc774 \uc7a5\ube44\ub294 0.2\ub9c8\uc774\ud06c\ub860 \uae30\uacf5\uc758 \uc911\uacf5\uc0ac\ub9c9\uc744 \uc0ac\uc6a9\ud558\uc5ec \uc6d0\uc2ec\ubd84\ub9ac \uc5c6\uc774 \ud608\uc7a5\uacfc \uc138\ud3ec \uc131\ubd84\uc744 \ubd84\ub9ac\ud558\uc5ec \ud608\uc18c\ud310 \uc190\uc0c1\uc744 \ucd5c\uc18c\ud654\ud558\uace0 \ub2e8\uc77c \uacf5\uc5ec\uc790 \ud608\uc18c\ud310 \uc218\uc728\uc744 18~22% \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 11\uc6d4: \ud14c\ub8e8\ubaa8 \ud608\uc561 \ubc0f \uc138\ud3ec \uae30\uc220(Terumo BCT)\uc740 Terumo Medical Products (Hangzhou) Co., Ltd.\uc640\uc758 \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud574 \uc911\uad6d \ud604\uc9c0\ud654 \uc804\ub7b5\uc744 \uc2dc\uc791\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ud14c\ub8e8\ubaa8 BCT\uc758 \uc911\uad6d \uc2dc\uc7a5 \ud604\uc9c0 \uc81c\uc870\uc758 \uccab\uac78\uc74c\uc785\ub2c8\ub2e4.<br \/>\n*   2024\ub144 6\uc6d4: Mallinckrodt\uc758 \uc790\ud68c\uc0ac\uc778 Therakos\ub294 CELLEX \uad11\ubd84\ub9ac\ubc18\ucd9c\uc220 \uc2dc\uc2a4\ud15c\uc5d0 \ub300\ud55c FDA \uc2dc\ud310 \uc804 \uc2b9\uc778\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4. \uc774 \uc2dc\uc2a4\ud15c\uc740 \uc778\ub77c\uc778 \ubc84\ud53c\ucf54\ud2b8 \ubd84\ub9ac \uae30\ub2a5\uc744 \ud1b5\ud569\ud558\uc5ec \uc2dc\uc220 \uc2dc\uac04\uc744 4\uc2dc\uac04\uc5d0\uc11c 3\uc2dc\uac04 \ubbf8\ub9cc\uc73c\ub85c \ub2e8\ucd95\ud558\uace0 \uc801\ud608\uad6c \uc624\uc5fc\uc744 40% \uac10\uc18c\uc2dc\ud0b5\ub2c8\ub2e4. \uc774\ub294 \uc2a4\ud14c\ub85c\uc774\ub4dc \ubd88\uc751\uc131 \uc774\uc2dd\ud3b8\ub300\uc219\uc8fc\ubcd1 \ubc0f \ud53c\ubd80 T\uc138\ud3ec \ub9bc\ud504\uc885\uc5d0 \ub300\ud574 \uc2b9\uc778\ub41c \ucd5c\ucd08\uc758 \ucc28\uc138\ub300 \uccb4\uc678 \uad11\ud654\ud559 \uce58\ub8cc \ud50c\ub7ab\ud3fc\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \ud608\uc561 \uc131\ubd84 \ubd84\ub9ac \ubc0f \uc815\ud654 \uae30\uc220\uc778 \uc544\ud398\ub808\uc2dc\uc2a4(Apheresis) \uc2dc\uc7a5\uc5d0 \ub300\ud55c \uc2ec\uce35\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc544\ud398\ub808\uc2dc\uc2a4\ub294 \uae30\uc99d\uc790 \ub610\ub294 \ud658\uc790\uc758 \ud608\uc561\uc5d0\uc11c \ud2b9\uc815 \uc131\ubd84\uc744 \ubd84\ub9ac\ud55c \ud6c4 \ub098\uba38\uc9c0\ub97c \ub2e4\uc2dc \uc21c\ud658\uc2dc\ud0a4\ub294 \uc758\ub8cc \uae30\uc220\ub85c, \uc6d0\uc2ec\ubd84\ub9ac \ub610\ub294 \ub9c9 \uc5ec\uacfc \uae30\uc220\uc744 \ud65c\uc6a9\ud558\uc5ec \ud608\uc561 \uc131\ubd84\uc744 \ubd84\ub9ac\ud558\uac70\ub098 \uc9c8\ubcd1 \uce58\ub8cc\uc5d0 \uc0ac\uc6a9\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc131\uc7a5 \ub3d9\ub825:<br \/>\n\uae00\ub85c\ubc8c \uc544\ud398\ub808\uc2dc\uc2a4 \uc2dc\uc7a5\uc740 2026\ub144 41\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 54\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \ud608\uc561\ud559\uc801 \ubc0f \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00, \ud608\uc7a5 \uc720\ub798 \uce58\ub8cc\uc81c \ubc0f \ud608\uc561 \uc131\ubd84\uc5d0 \ub300\ud55c \uc218\uc694 \uc99d\ub300, \uc790\ub3d9\ud654 \ubc0f \ub9c9 \uc5ec\uacfc \uae30\uc220\uc758 \ubc1c\uc804 \ub4f1 \uc5ec\ub7ec \uc694\uc778\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub429\ub2c8\ub2e4. \ud2b9\ud788 \ubc31\ud608\uad6c\ubd84\ub9ac\uc220(Leukapheresis)\uc744 \ud544\uc694\ub85c \ud558\ub294 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\ubc95\uc758 \ud655\uc7a5, \ud734\ub300\uc6a9 \ud604\uc7a5 \uc9c4\ub8cc \uc544\ud398\ub808\uc2dc\uc2a4 \uc2dc\uc2a4\ud15c\uc758 \ucd9c\ud604, \uadf8\ub9ac\uace0 \uc800\ud3d0\uae30\ubb3c \uc77c\ud68c\uc6a9 \ud0a4\ud2b8\uc5d0 \ub300\ud55c ESG(\ud658\uacbd, \uc0ac\ud68c, \uc9c0\ubc30\uad6c\uc870) \uc911\uc2ec \ud22c\uc790\uac00 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ud68c\uc6a9\ud488 \ubc0f \uc18c\ubaa8\ud488 \ubd80\ubb38\uc740 \uac10\uc5fc \uad00\ub9ac \ubc0f ESG \ubaa9\ud45c \ucda9\uc871\uc5d0 \uae30\uc5ec\ud558\uba70 7.24%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uae30\uae30 \ubd80\ubb38\ubcf4\ub2e4 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n\ubc18\uba74, \ub192\uc740 \ucd08\uae30 \ud22c\uc790 \ube44\uc6a9\uacfc \uc18c\ubaa8\ud488 \ube44\uc6a9\uc740 \ubcd1\uc6d0\uc758 \ud22c\uc790 \uc218\uc775\ub960\uc744 \uac10\uc18c\uc2dc\ud0a4\ub294 \uc8fc\uc694 \uc81c\uc57d \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \ub610\ud55c, \uc219\ub828\ub41c \uc804\ubb38 \uc778\ub825 \ubd80\uc871, \ud575\uc2ec \uc77c\ud68c\uc6a9\ud488\uc758 \uacf5\uae09\ub9dd \uc704\ud5d8, \uadf8\ub9ac\uace0 \ubcd1\uc6d0\uccb4 \uac10\uc18c \uc804\ud608 \uae30\uc220\uacfc\uc758 \uacbd\uc7c1 \ub610\ud55c \uc2dc\uc7a5 \ud655\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc9c0\ubaa9\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654 \ubc0f \uc8fc\uc694 \uc131\uc7a5 \ubd84\uc57c:<br \/>\n\ubcf4\uace0\uc11c\ub294 \uc81c\ud488(\uae30\uae30, \uc77c\ud68c\uc6a9\ud488 \ubc0f \uc18c\ubaa8\ud488), \uc2dc\uc220(\ud608\uc7a5\ubd84\ub9ac\uc220, \ud608\uc18c\ud310\ubd84\ub9ac\uc220, \ubc31\ud608\uad6c\ubd84\ub9ac\uc220, \uc801\ud608\uad6c\ubd84\ub9ac\uc220, \uad11\ubd84\ub9ac\uc220), \uae30\uc220(\uc6d0\uc2ec\ubd84\ub9ac, \ub9c9 \ubd84\ub9ac), \uc801\uc6a9 \ubd84\uc57c(\ud608\uc561\ud559\uc801, \uc2e0\uacbd\ud559\uc801, \uc2e0\uc7a5, \uc790\uac00\uba74\uc5ed \uc9c8\ud658 \ub4f1), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\ud608\uc561 \uc740\ud589 \ubc0f \uc131\ubd84 \uacf5\uae09\uc790, \ubcd1\uc6d0 \ubc0f \uc218\ud608 \uc13c\ud130, \uc678\ub798 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9), \uadf8\ub9ac\uace0 \uc9c0\uc5ed\ubcc4(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>\uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc220\uc740 \uad11\ubc94\uc704\ud55c CMS(\uba54\ub514\ucf00\uc5b4 \ubc0f \uba54\ub514\ucf00\uc774\ub4dc \uc11c\ube44\uc2a4 \uc13c\ud130) \uc801\uc6a9 \ubc94\uc704 \ud655\ub300\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 8.35%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\ub294 \uad11\ubd84\ub9ac\uc220(Photopheresis)\uc785\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uae30\uae30 \uc2b9\uc778 \uac00\uc18d\ud654 \ubc0f \ud608\uc7a5 \uc790\uae09\uc790\uc871 \uc774\ub2c8\uc154\ud2f0\ube0c\uc5d0 \ub530\ub77c 8.08%\uc758 \uac00\uc7a5 \ub192\uc740 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubc0f \ubbf8\ub798 \uc804\ub9dd:<br \/>\n\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 Asahi Kasei Corporation, B. Braun SE, Baxter International Inc., Fresenius SE &#038; Co. KGaA, Grifols S.A., Haemonetics Corporation, Terumo Corporation \ub4f1 \uc8fc\uc694 20\uac1c \uae30\uc5c5\uc758 \ud504\ub85c\ud544\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd, \ubbf8\ucda9\uc871 \uc218\uc694 \ud3c9\uac00\ub97c \ub2e4\ub8e8\uba70, \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc774 \uc804\ub7b5\uc801 \uc758\uc0ac\uacb0\uc815\uc744 \ub0b4\ub9b4 \uc218 \uc788\ub3c4\ub85d \uc9c0\uc6d0\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-60010","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/60010"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=60010"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/60010\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=60010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=60010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=60010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}